Friday 6 November 2026
Export CMT’s income statement to Excel — free account
Core Molding Technologies Inc
CMT Basic Materials Specialty Chemicals
Core Molding Technologies Inc’s revenue for fiscal 2025 (year ended December 2025) was $273.8 million, down 9.45% from fiscal 2024.
- Revenue
- +54.4%
- EPS
- −18.2%
- Free cash flow
- −3,170.5%
- Total debt
- −76.7%
Quarter to September 2026, against a year earlier
21.59
0.54
+2.57%
Follow CMT
Alert me
| Sep '26 From the 10-Q filed 4 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
27.74 | 27.44 | 20.00 | 15.42 |
+8 more quarters Free account |
P/S ratio |
0.68 | 0.80 | 0.71 | 0.63 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 89.62 | |
P/Operating CF |
(52.76) | 12.42 | (20.81) | 34.23 | |
P/B ratio |
1.21 | 1.26 | 1.21 | 1.09 | |
Price to Tangible BV |
1.38 | 1.44 | 1.40 | 1.25 | |
EV/Sales |
0.69 | 0.82 | 0.69 | 0.56 | |
EV/EBITDA |
9.93 | 9.79 | 7.72 | 5.78 | |
EV/Operating CF |
23.46 | 12.58 | 48.70 | 8.00 | |
EV/FCF |
(10.21) | (25.25) | (12.18) | 80.05 | |
Quick Ratio |
1.09 | 1.19 | 1.76 | 2.21 | |
Current Ratio |
1.86 | 2.00 | 2.41 | 3.02 | |
Net Debt/EBITDA |
(0.15) | (2.22) | (1.11) | (2.85) | |
Debt/Assets |
2.08% | 0.00% | 7.95% | 8.64% | |
Debt/Equity |
0.03 | 0.00 | 0.12 | 0.12 | |
Asset Turnover |
1.27 | 1.14 | 1.16 | 1.25 | |
Operating CF/Net income |
(2.45) | 9.14 | (15.25) | 1.63 | |
Capex/Depreciation |
(3.03) | (2.61) | (1.24) | (2.80) | |
Interest Coverage |
— | 38.25 | 8.88 | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
13.07% | 16.63% | 19.14% | 10.38% | |
Intangible Assets out of Total Assets |
0.09 | 0.09 | 0.09 | 0.09 | |
Share Based Compensation of Revenue |
0.58% | 0.80% | 0.84% | 0.19% | |
Graham Net Nets |
0.14 | 0.15 | 0.17 | 0.19 | |
Graham Number |
18.61 | 19.06 | 21.56 | 23.24 | |
Earnings Yield |
3.60% | 3.64% | 5.00% | 6.48% | |
Free Cash Flow Yield |
(9.87%) | (4.10%) | (8.03%) | 1.12% | |
Revenue per Share |
10.52 | 7.31 | 6.83 | 8.71 | |
Operating CF per Share |
(0.43) | 1.90 | (1.08) | 0.59 | |
Capex per Share |
(0.89) | (0.97) | (0.44) | (0.93) | |
Free Cash Flow per Share |
(1.32) | 0.93 | (1.52) | (0.34) | |
Cash per Share |
0.63 | 1.41 | 2.74 | 4.44 | |
Shareholders Equity per Share |
18.78 | 18.77 | 18.45 | 18.46 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
18.78 | 18.77 | 18.45 | 18.46 | |
Free Cash Flow |
(11.32) | 8.00 | (13.01) | (2.94) | |
Working Capital |
45.05 | 48.07 | 68.57 | 69.16 | |
Capital Expenditures |
(7.62) | (8.30) | (3.78) | (7.96) | |
Net Current Asset Value |
27.52 | 29.96 | 32.94 | 33.37 | |
EV/EBIT |
23.88 | 22.73 | 15.47 | 10.79 | |
Capex to Sales |
0.08 | 0.13 | 0.06 | 0.11 | |
Price to Operating Income |
23.69 | 21.95 | 15.82 | 12.08 | |
| Other line items | |||||
Average Receivables |
46.25 | 44.35 | 51.47 | 36.69 | |
Average Payables |
24.90 | 23.22 | 23.00 | 16.02 | |
Average Inventory |
23.25 | 23.35 | 20.86 | 19.03 | |
Average Assets |
225.33 | 223.67 | 232.97 | 218.84 | |
Average Common Equity |
158.29 | 157.27 | 154.05 | 152.77 |
Columns are period end dates · fundamentals updated 4 Nov 2026